Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma

Xiaofen Li,1,2,* Xia Li,3,* Xuefeng Fang,1 Ying Yuan1 1Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China; 2Department of Abdominal Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan, China; 3Department...

Full description

Bibliographic Details
Main Authors: Li X, Fang X, Yuan Y
Format: Article
Language:English
Published: Dove Medical Press 2018-07-01
Series:OncoTargets and Therapy
Subjects:
Online Access:https://www.dovepress.com/long-term-progression-free-survival-of-third-line-apatinib-in-lung-squ-peer-reviewed-article-OTT